501
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Impacts of travel duration on urban-rural resident free vaccination behavior: Chinese COVID-19 vaccine booster dose evidence

, , , , , , , , , , , , , & show all
Article: 2352914 | Received 12 Mar 2024, Accepted 06 May 2024, Published online: 06 Jun 2024

References

  • Miao Y, Zhang W, Li Y, Wu J, Xu D, Gu J, Wang M, Wei W, Ye B, Miao C, et al. Association between lifestyle and COVID-19 vaccination: a national cross-sectional study. Front Public Health. 2022;10:918743. doi:10.3389/fpubh.2022.918743.
  • Benati I, Coccia M. Global analysis of timely COVID-19 vaccinations: improving governance to reinforce response policies for pandemic crises. Int J Health Gov. 2022;27(3):240–8. doi:10.1108/IJHG-07-2021-0072.
  • Coccia M. Pandemic prevention: lessons from COVID-19. Encyclopedi. 2022;1(2):433–44. doi:10.3390/encyclopedia1020036.
  • Hassan MM, Tahir MH, Ameeq M, Jamal F, Mendy JT, Chesneau C. Risk factors identification of COVID-19 patients with chronic obstructive pulmonary disease: a retrospective study in Punjab-Pakistan. Immunity Inflam Disease. 2023;11(8):e981. doi:10.1002/iid3.981.
  • Muneeb HM, Ameeq M, Jamal F, Tahir MH, Mendy JT. Prevalence of COVID-19 among patients with chronic obstructive pulmonary disease and tuberculosis. Ann Med. 2023;55(1):285–91. doi:10.1080/07853890.2022.2160491.
  • Coccia M. Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: a global analysis. Environ Res. 2022;204:112314. doi:10.1016/j.envres.2021.112314.
  • Coccia M. Improving preparedness for next pandemics: max level of COVID-19 vaccinations without social impositions to design effective health policy and avoid flawed democracies. Environ Res. 2022;213:113566. doi:10.1016/j.envres.2022.113566.
  • Coccia M. Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency. AIMS Public Health. 2023;10(1):145–68. doi:10.3934/publichealth.2023012.
  • Shi H, Goulias KG. Long-term effects of COVID-19 on time allocation, travel behavior, and shopping habits in the United States. J Transp Health. 2024;34:101730. doi:10.1016/j.jth.2023.101730.
  • Mathieu P, Gautier A, Raude J, Goronflot T, Launay T, Debin M, Guerrisi C, Turbelin C, Hanslik T, Jestin C, et al. Population perception of mandatory childhood vaccination programme before its implementation, France, 2017. Euro Surveill. 2019;24(25):1900053. doi:10.2807/1560-7917.ES.2019.24.25.1900053.
  • Ishida M, Mulou N, Mahal A. Travel time to health facilities in Papua New Guinea: implications for coverage and equity in child vaccinations. Vaccine. 2022;40(38):5556–61. doi:10.1016/j.vaccine.2022.07.060.
  • Miao Y, Bai J, Shen Z, Li Y, Zhang W, Zhu D, Ren R, Zhang J, Guo D, Tarimo CS, et al. How urban versus rural population relates to COVID-19 booster vaccine hesitancy: a propensity score matching design study. Human Vaccines Immunother. 2024;20(1):2297490. doi:10.1080/21645515.2023.2297490.
  • Okwaraji YB, Mulholland K, Schellenberg JRMA, Andarge G, Admassu M, Edmond KM. The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community based cross sectional study. BMC Public Health. 2012;12(1):476. doi:10.1186/1471-2458-12-476.
  • Wu J, Li Q, Silver TC, Wang M, Gu J, Wei W, Ma M, Zhao L, Mu Z, Miao Y. COVID-19 vaccine hesitancy among Chinese population: a large-scale national study. Front Immunol. 2021;12:781161. doi:10.3389/fimmu.2021.781161.
  • Smith PJ, Santoli JM, Chu SY, Ochoa DQ, Rodewald LE. The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program. Pediatrics. 2020;116(1):130–9. doi:10.1542/peds.2004-1058.
  • Coccia M. COVID-19 vaccination is not a sufficient public policy to face crisis management of next pandemic threats. Public Organiz Rev. 2023;23(4):1353–67. doi:10.1007/s11115-022-00661-6.
  • Magazzino C, Mele M, Coccia M. A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality. Epidemiol Infect. 2022;150:e168. doi:10.1017/S0950268822001418.
  • Chew NWS, Cheong C, Kong G, Phua K, Ngiam JN, Tan BYQ, Wang B, Hao F, Tan W, Han X, et al. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. Int J Infect Dis. 2020;106:52–60. doi:10.1016/j.ijid.2021.03.069.
  • Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–21. doi:10.1016/S2468-2667(21)00012-8.
  • Hassan MM, Ameeq M, Fatima L, Naz S, Sikandar SM, Kargbo A, Abbas S. Assessing socio-ecological factors on caesarean section and vaginal delivery: an extended perspective among women of South-Punjab, Pakistan. J Psychosom Obstet Gynaecol. 2023;44(1):2252983. doi:10.1080/0167482X.2023.2252983.
  • Biswas RK, Afiaz A, Huq S, Farzana M, Kabir E. Public opinion on COVID-19 pandemic in Bangladesh: disruption to public lives and trust in government’s immunisation performance. Int J Health Plann Manage. 2024;39(1):119–34. doi:10.1002/hpm.3721.
  • Giannouchos TV, Li Z, Hung P, Li X, Olatosi B. Rural-urban disparities in hospital admissions and mortality among patients with COVID-19: evidence from South Carolina from 2021–2022. J Community Health. 2023;48(5):824–33. doi:10.1007/s10900-023-01216-6.
  • Mayuzumi Y. After the COVID-19 pandemic, are residents in rural areas happier than those in urban areas? Asia-Pac J Reg Sci. 2023;7(4):1055–90. doi:10.1007/s41685-023-00312-8.
  • Thaker J, Floyd B. Shifting COVID-19 vaccine intentions in New Zealand: next steps in the vaccination campaign. Lancet Reg Health West Pac. 2021;15:100278. doi:10.1016/j.lanwpc.2021.100278.
  • Zhong J, Zhong Q, Xiong H, Wu D, Zheng C, Liu S, Zhong Q, Chen Y, Zhang D. Public acceptance of COVID-19 control measures and associated factors during Omicron-dominant period in China: a cross-sectional survey. BMC Public Health. 2024;24(1):543. doi:10.1186/s12889-024-17646-3.
  • Weinstein N, Schwarz K, Chan I, Kobau R, Alexander R, Kollar L, Rodriguez L, Mansergh G, Repetski T, Gandhi P. et al. COVID-19 vaccine hesitancy among US adults: safety and effectiveness perceptions and messaging to increase vaccine confidence and intent to vaccinate. Public Health Rep. 2024;139(1):102–11. doi:10.1177/00333549231204419.
  • National Bureau of Statistics of China. Communiqué of the seventh national population census (No. 7). [accessed 2024 Apr 11]. https://www.stats.gov.cn/english/PressRelease/202105/t20210510_1817192.html.
  • Wang T, Zeng R. Addressing inequalities in China’s health service. Lancet. 2015;386(10002):1441. doi:10.1016/S0140-6736(15)00402-X.
  • Wu J, Shen Z, Li Q, Tarimo CS, Wang M, Gu J, Wei W, Zhang X, Huang Y, Ma M, et al. How urban versus rural residency relates to COVID-19 vaccine hesitancy: a large-scale national Chinese study. Soc Sci Med. 2023;320:115695. doi:10.1016/j.socscimed.2023.115695.
  • Moore M, Gould P, Keary BS. Global urbanization and impact on health. Int J Hyg Envir Heal. 2003;206(4–5):269–78. doi:10.1078/1438-4639-00223.
  • Weiss DJ, Nelson A, Gibson HS, Temperley W, Peedell S, Lieber A, Hancher M, Poyart E, Belchior S, Fullman N, et al. A global map of travel time to cities to assess inequalities in accessibility in 2015. Nature. 2018;553(7688):333–6. doi:10.1038/nature25181.
  • Kulu H, Dorey P. Infection rates from covid-19 in Great Britain by geographical units: a model-based estimation from mortality data. Health & Place. 2021;67:102460. doi:10.1016/j.healthplace.2020.102460.
  • Cameron RL, Kavanagh K, Pan J, Love J, Cuschieri K, Robertson C, Ahmed S, Palmer T, Pollock KGJ. Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013. Emerg Infect Dis. 2016;22(1):56–64. doi:10.3201/eid2201.150736.
  • Tabrizi SN, Brotherton JML, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, et al. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. Lancet Infect Dis. 2014;14(10):958–66. doi:10.1016/S1473-3099(14)70841-2.
  • An Z, Wang F, Pan A, Yin Z, Rodewald L, Feng Z. Vaccination strategy and challenges for consolidating successful containment of COVID-19 with population immunity in China. BMJ. 2021;375:e066125. doi:10.1136/bmj-2021-066125.
  • Veronese N, Saccaro C, Demurtas J, Smith L, Dominguez LJ, Maggi S, Barbagallo M. Prevalence of unwillingness and uncertainty to vaccinate against COVID-19 in older people: a systematic review and meta-analysis. Ageing Res Rev. 2022;72:101489. doi:10.1016/j.arr.2021.101489.
  • Rahman IU, Austin A, Nelson N. Willingness to COVID-19 vaccination: empirical evidence from EU. Heliyon. 2023;9(5):e15776. doi:10.1016/j.heliyon.2023.e15776.
  • Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, Wang W, Chen X, Zhao Y. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat Med. 2023;29(3):623–31. doi:10.1038/s41591-023-02241-7.
  • Yang J, Zheng W, Shi H, Yan X, Dong K, You Q, Zhong G, Gong H, Chen Z, Jit M, et al. Who should be prioritized for COVID-19 vaccination in China? A descriptive study. BMC Med. 2021;19(1):45. doi:10.1186/s12916-021-01923-8.
  • Ding D, Zhang R. China’s COVID-19 control strategy and its impact on the global pandemic. Front Public Health. 2022;10:857003. doi:10.3389/fpubh.2022.857003.
  • Milošević ĐJ, Mari S, Vdović M, Milošević A. Links between conspiracy beliefs, vaccine knowledge, and trust: anti-vaccine behavior of Serbian adults. Social Science & Medicine. 2021;277:113930. doi:10.1016/j.socscimed.2021.113930.
  • de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020;396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • Wu J, Xia Q, Miao Y, Yu C, Tarimo CS, Yang Y. Self-perception and COVID-19 vaccination self-efficacy among Chinese adults: a moderated mediation model of mental health and trust. J Affect Disord. 2023;333:313–20. doi:10.1016/j.jad.2023.04.047.
  • Cai J, Deng X, Yang J, Sun K, Liu H, Chen Z, Peng C, Chen X, Wu Q, Zou J, et al. Modeling transmission of SARS-CoV-2 omicron in China. Nat Med. 2022;28(7):1468–75. doi:10.1038/s41591-022-01855-7.
  • Sturgis P, Brunton-Smith I, Jackson J. Trust in science, social consensus and vaccine confidence. Nat Hum Behav. 2021;5(11):1528–34. doi:10.1038/s41562-021-01115-7.
  • Toledo-López A, Leyva-Hernández SN, Jiménez-Castañeda JC, Avendaño-Rito MDC. Determinants for COVID-19 vaccination intention in Mexico. Heliyon. 2023;9(8):e18079. doi:10.1016/j.heliyon.2023.e18079.
  • Van Oost P, Yzerbyt V, Schmitz M, Vansteenkiste M, Luminet O, Morbée S, Van den Bergh O, Waterschoot J, Klein O. The relation between conspiracism, government trust, and COVID-19 vaccination intentions: the key role of motivation. Soc Sci Med. 2022;301:114926. doi:10.1016/j.socscimed.2022.114926.